z-logo
Premium
Peroxisome proliferator‐activated receptor γ contributes to T lymphocyte apoptosis during sepsis
Author(s) -
Soller Mathias,
Tautenhahn Anja,
Brüne Bernhard,
Zacharowski Kai,
John Stefan,
Link Hartmut,
Knethen Andreas
Publication year - 2006
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0205058
Subject(s) - sepsis , peroxisome proliferator activated receptor , biology , apoptosis , agonist , ppar agonist , immunology , receptor , cancer research , microbiology and biotechnology , biochemistry
In the last two decades, extensive research failed to significantly improve the outcome of patients with sepsis. In part, this drawback is based on a gap in our knowledge about molecular mechanisms understanding the pathogenesis of sepsis. During sepsis, T cells are usually depleted. Recent studies in mice and human cells suggested a role of the peroxisome proliferator‐activated receptor γ (PPARγ) in provoking apoptosis in activated T lymphocytes. Therefore, we studied whether expression/activation of PPARγ might contribute to T cell death during sepsis. We observed PPARγ up‐regulation in T cells of septic patients. In contrast to controls, PPARγ expressing cells from septic patients responded with apoptosis when exposed to PPARγ agonists. Cell demise was attenuated by SR‐202, a synthetic PPARγ antagonist, and specificity was further verified by excluding a proapoptotic response to a PPARα agonist. We propose that up‐regulation of PPARγ sensitizes T cells of septic patients to undergo apoptosis. PPARγ activation in T cells requires an exogenous PPARγ agonist, which we identified in sera of septic patients. Septic sera were used to study reporter gene expression containing a PPAR‐responsive element. We conclude that PPARγ plays a significant role in T cell apoptosis, contributing to lymphocyte loss in sepsis. Thus, inhibition of PPARγ may turn out to be beneficial for patients suffering from lymphopenia during sepsis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here